{
  "record": {
    "record_type": "FDA_OUTCOME_VERIFICATION",
    "record_version": "1.1",
    "catalyst_id": "iron-bitopertin-2026-03-25b",
    "company": "Disc Medicine, Inc.",
    "ticker": "IRON",
    "drug": "Bitopertin",
    "indication": "Erythropoietic Protoporphyria (EPP)",
    "application_type": "NDA",
    "scheduled_pdufa": "2026-03-25",
    "odin_version": "v10.67",
    "odin_parameters": 46,
    "odin_probability": 0.6593,
    "odin_tier": "TIER_3",
    "odin_action": "SMALL_POSITION_EARLY_EXIT",
    "odin_exit_window": "T-5 to T-7",
    "odin_runner": "20%",
    "odin_ta_risk": "HIGH_RISK",
    "odin_signals": {
      "inexperienced_sponsor": -1.2875,
      "BTD": 0.1676,
      "orphan": 0.1469,
      "ta_high_risk": -0.2555,
      "novice_high_risk_ta": -0.4071,
      "surrogate_only": -0.45,
      "first_in_class": 0.45,
      "unmet_need": 0.55,
      "designation_stack": 0.35
    },
    "odin_total_adjustment": -0.7356,
    "odin_logit": 0.6601,
    "fda_outcome": "CRL",
    "fda_outcome_date": "2026-02-13",
    "fda_outcome_note": "CRL issued 40 days BEFORE scheduled PDUFA (2026-03-25). Early CRL.",
    "fda_outcome_description": "Complete Response Letter — FDA concluded AURORA and BEACON trials did not sufficiently demonstrate association between PPIX reduction (surrogate biomarker) and sunlight exposure-based clinical endpoints, despite acknowledging strong mechanistic plausibility.",
    "fda_key_issue": "Surrogate endpoint insufficiency — exactly matching ODIN surrogate_only signal",
    "source_url": "https://www.globenewswire.com/news-release/2026/02/13/3238299/0/en/Disc-Medicine-Receives-Complete-Response-Letter-from-FDA-for-Bitopertin-for-the-Treatment-of-EPP.html",
    "trade": {
      "executed": true,
      "entry_date": "2026-01-30",
      "entry_price": 77.11,
      "exit_date": "2026-02-06",
      "exit_price": 80.31,
      "holding_period_days": 7,
      "gain_per_share": 3.2,
      "gain_percent": 4.15,
      "position_sizing": "SMALL (per ODIN Tier 3 guidance)",
      "exit_rationale": "ODIN SMALL_POSITION_EARLY_EXIT — exited 7 days before CRL"
    },
    "stock_impact": {
      "crl_date": "2026-02-13",
      "crl_decline_percent": 22,
      "estimated_post_crl_price": 62.64,
      "loss_avoided_per_share": 17.67,
      "loss_avoided_percent": 22,
      "net_swing_vs_holding": 26.15,
      "days_between_exit_and_crl": 7
    },
    "odin_classification": "WIN",
    "classification_rationale": "ODIN Tier 3 (65.9%) with SMALL_POSITION_EARLY_EXIT. Actual trade: +4.15% captured during runup, exited Feb 6. CRL hit Feb 13 (-22%). Net swing +26.1% vs buy-and-hold. ODIN surrogate_only signal directly predicted FDA rationale.",
    "signal_validation": {
      "surrogate_only": {
        "weight": -0.45,
        "fda_rationale_match": "EXACT",
        "description": "ODIN flagged PPIX as surrogate-only endpoint. FDA CRL stated trials did not sufficiently show association between PPIX reduction and clinical endpoints. Word-for-word match to signal thesis."
      },
      "inexperienced_sponsor": {
        "weight": -1.2875,
        "fda_rationale_match": "CONFIRMED",
        "description": "Disc Medicine first NDA submission. Company acknowledged CRL delays potential approval, plans Type A meeting — consistent with inexperienced navigation."
      },
      "ta_high_risk": {
        "weight": -0.2555,
        "fda_rationale_match": "CONFIRMED",
        "description": "Hematology HIGH_RISK classification validated. FDA applied elevated scrutiny to endpoint package."
      },
      "novice_high_risk_ta": {
        "weight": -0.4071,
        "fda_rationale_match": "CONFIRMED",
        "description": "Interaction: inexperienced sponsor in high-risk TA. Compounding risk realized — company unable to anticipate FDA surrogate endpoint concerns pre-submission."
      }
    },
    "prior_record_hash": "f1a3ce3996557aa0956d00460a5504a2d0b0dafef3c947e45bb1cbb3b7786b74",
    "prior_git_commit": "3f1f835",
    "timestamp_utc": "2026-02-14T03:52:19.805Z",
    "timestamp_unix": 1771041139
  },
  "integrity": {
    "algorithm": "SHA-256",
    "hash": "2f75e484b8f37a7696c90527b4820d6604f8ea5be594ad29145980ba05f3d3d3",
    "chain": "This record supersedes and chains from prior_record_hash. Both git commits form an immutable audit trail.",
    "verification": "To verify: JSON.stringify(record, null, 2) → SHA-256 must equal hash field."
  }
}